ITCI
Intra-Cellular Therapies Inc
Price:  
66.37 
USD
Volume:  
913,664.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ITCI WACC - Weighted Average Cost of Capital

The WACC of Intra-Cellular Therapies Inc (ITCI) is 7.2%.

The Cost of Equity of Intra-Cellular Therapies Inc (ITCI) is 10.70%.
The Cost of Debt of Intra-Cellular Therapies Inc (ITCI) is 5.00%.

Range Selected
Cost of equity 8.70% - 12.70% 10.70%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.2% - 8.2% 7.2%
WACC

ITCI WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.04 1.39
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.70% 12.70%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.2% 8.2%
Selected WACC 7.2%